Apr 1, 2026 | News, Press Review
Touchpoint, an editorial publication focused on the intersection between markets and innovation, dedicated a feature in its February–March print edition to Hemera, including an interview with Cristiana Vignoli, Chief Executive Officer of the company. The interview...
Mar 27, 2026 | News, Press Review
In January 2026, following the dissemination of the scientific preprint on the cell therapy REMaST published in the international scientific journal Immunity by Cell Press,Hemera received significant national media coverage, confirming the growing interest in...
Mar 23, 2026 | News, Press Review
Hemera is featured in an article published by Osservatorio Terapie Avanzate, a leading Italian editorial platform focused on scientific information and analysis of innovations in advanced therapies, regenerative medicine, and biotechnology. In the interview, Cristiana...
Jan 27, 2026 | News, Press Review
The cell therapy REMaST, developed by Hemera for the regeneration of nervous tissue in spinal cord injuries, was the focus of a dedicated report on TG3 Leonardo, the Italian public broadcaster’s science and technology program. The segment highlighted the innovative...
Jun 28, 2024 | News, Press Review
We are excited to announce our participation in the FENS Forum 2024, the largest European congress dedicated to neuroscience, taking place from June 25 to 29 in Vienna. The teams from the Therapy Development Department and the Research and Development Department,...
May 28, 2024 | News, Press Review
Hemera enthusiastically participated in ISCT 2024, the event organized by the International Society for Cell & Gene Therapy, held in Vancouver from May 28 to June 2. During this conference, Hemera was present in the Innovation Zone, an area dedicated to the most...
